Showing results (701-710 of 16,632) with videos related to
Sort By:
Pageof 1,664
Cancer Letters|May 28, 2025
Formation of polyploid giant cancer cells and the transformative role of human cytomegalovirus IE1 proteinRanim El Baba, Sandy Haidar Ahmad, Caroline Vanhulle, et al.Cancer Letters|May 25, 2025
Fusobacterium nucleatum enhances cholesterol biosynthesis in colorectal cancer via miR-130a-3p-mediated AMPK inhibition, a process counteracted by butyrateYuting Sun, Jiawei Lu, Effie Yin Tung Lau, et al.Cancer Letters|May 26, 2025
CDC34 suppresses macrophage phagocytic activity and predicts poor response to immune checkpoint inhibitor in cancersXiao-Liang Jie, Jia-Cong Wei, Di Wang, et al.Cancer Letters|May 21, 2025
SMARCA4: Promises and challenges in the treatment of cancersWei Ye, Ding An, Wen-Bin OuCancer Letters|May 22, 2025
N-acetyl-L-cysteine promoted hematopoietic recovery in patients with acute myeloid leukemia after complete remission--A pilot studyLi-Juan Hu, Chen-Yuan Li, Tong Xing, et al.Cancer Letters|May 17, 2025
YAP/TAZ: An epitome of tumorigenesisSoumya Mukherjee, Emily A Warden, Jianmin ZhangCancer Letters|June 14, 2025
The Role of Tumor Microenvironment and Immune Cell Crosstalk in Triple-Negative Breast Cancer (TNBC): Emerging Therapeutic OpportunitiesHussein Sabit, Amro Adel, Mariam M Abdelfattah, et al.Cancer Letters|June 12, 2025
Identification of an Individualized Immune-Related miRNA Pair Signature for Survival Prediction of Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell CancerPeng Wu, Dexin Shang, Li Liu, et al.Cancer Letters|May 12, 2025
Efficacy and safety of inetetamab plus pertuzumab and nab-paclitaxel as neoadjuvant therapy for HER2+ breast cancer: A single-arm multicenter phase II clinical trialWen-Jia Zuo, Lin-Xiao-Xi Ma, Zhi-Hong Wang, et al.Cancer Letters|August 20, 2025
The IRE1α/XBP1-mediated upregulation of LMTK2 attenuates endoplasmic reticulum stress by enhancing autophagic activityJie Lun, Xiuxiu Li, Rongjing Zhang, et al.Pageof 1,664